Bill Ringo has joined Sofinnova Ventures as an executive-in-residence, focused on the life sciences market. He is the former president and CEO of Abgenix Inc., which was sold to Amgen last year for $2.7 billion. www.sofinnova.com
Bill Ringo has joined Sofinnova Ventures as an executive-in-residence, focused on the life sciences market. He is the former president and CEO of Abgenix Inc., which was sold to Amgen last year for $2.7 billion. www.sofinnova.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.